Sometimes profoundly important public health opportunities are discovered by accident.
To access this subscriber-only content please log in or subscribe.
If your institution has a site license, log in with IP-login or register for a sponsored account.* *Not all site licenses are enrolled in sponsored accounts.
Emeritus cancer center director, City of Hope Comprehensive Cancer Center, Former CEO, City of Hope; Former acting commissioner, FDA; Former associate director, NCI
In 2026, more than 900 million people are estimated to be regularly using generative artificial intelligence—computer systems capable of creating human-like text, images, audio, video, and other original content. AI is becoming integrated into nearly every aspect of daily life. Health care is no exception.
FDA has released a final guidance for drug sponsors conducting clinical trials of psychedelics, including psilocybin, LSD, and MDMA, for the treatment of psychiatric and substance abuse disorders.
A Mayo Clinic study published in the New England Journal of Medicine demonstrates that an off-the-shelf, dual-antibody therapy can generate deep and durable responses in extramedullary multiple myeloma—one of the most aggressive and treatment-resistant forms of the disease.
The Cancer Letter has published a number of excellent pieces lately on the importance of supporting and encouraging trainees and junior investigators during these uncertain times.
Researchers from UVA Cancer Center, the University of Virginia School of Medicine, and Inova Peterson Life with Cancer detail the many ways artificial intelligence could help ensure patients receive the support they need.
In this episode of In the Headlines, Paul Goldberg, publisher of The Cancer Letter, and Jacquelyn Cobb, associate editor, talk about controversial data cited in Trump’s “Make American Healthy Again” executive order that claims that the U.S. has the highest age-standardized incidence rate of cancer globally. But where did that data come from?
Emeritus cancer center director, City of Hope Comprehensive Cancer Center, Former CEO, City of Hope; Former acting commissioner, FDA; Former associate director, NCI
A modest proposal from a former FDA commissioner: Add antidepressants to the nation’s water supply
Warning: This is not a public health recommendation. Do not implement.
Sometimes profoundly important public health opportunities are discovered by accident.
Warning: This is not a public health recommendation. Do not implement.
YOU MAY BE INTERESTED IN
Like it or not, AI psycho-oncology care is already happening. Urgently needed: An ethical framework
Developers and mental health providers must share the same goal: Safe, equitable, trustworthy, and patient-centered care
FDA final guidance on psychedelics opens the door to psycho-oncology research
Guidance permits treatment without psychotherapy, alarming scientists, advocates
Off-the-shelf immunotherapy produces deep and durable responses in extramedulary MM, Mayo researchers find
How today’s uncertainty can motivate young investigators to double down on their passion
Lessons from my Studs Terkel boxed set
How AI will transform mental health support for breast cancer patients, narrative review paper details
In The Headlines: What’s up with the U.S. cancer incidence rate?